Mirum Pharmaceuticals (MIRM) EBIT (2019 - 2026)
Mirum Pharmaceuticals' quarterly EBIT came in at -$789.5 million in Q1 2026, down 5099.66% year-on-year from $15.8 million in Q1 2025, and down 17186.29% quarter-over-quarter from -$4.6 million in Q4 2025.
Mirum Pharmaceuticals has reported EBIT for 8 years, with the latest figure at -$789.5 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 5099.66% year-over-year to -$789.5 million; the trailing twelve-month figure through Mar 2026 stood at -$796.4 million (down 943.51% YoY), and the FY2025 full-year result was -$22.1 million, up 74.73% from the prior year.
- EBIT for Q1 2026 stood at -$789.5 million, down from -$4.6 million in the prior quarter.
- The five-year high for EBIT was $2.6 million in Q3 2025, with the low at -$789.5 million in Q1 2026.
- Average EBIT over 5 years is -$67.0 million, with a median of -$25.1 million recorded in 2023.
- Year-over-year, EBIT surged 120.52% in 2025 and slumped 5099.66% in 2026.
- Tracing MIRM's EBIT over 5 years: stood at -$34.2 million in 2022, then rose by 4.61% to -$32.6 million in 2023, then climbed by 25.67% to -$24.2 million in 2024, then jumped by 81.15% to -$4.6 million in 2025, then tumbled by 17186.29% to -$789.5 million in 2026.
- The last three EBIT figures came in at -$789.5 million (Q1 2026), -$4.6 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn | -789.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -789.47 Mn |
| Dec 31, 2025 | -4.57 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | -4.99 Mn |
| Mar 31, 2025 | -15.18 Mn |
| Dec 31, 2024 | -24.22 Mn |
| Sep 30, 2024 | -12.68 Mn |
| Jun 30, 2024 | -24.23 Mn |
| Mar 31, 2024 | -26.47 Mn |
| Dec 31, 2023 | -32.59 Mn |
| Sep 30, 2023 | -25.15 Mn |
| Jun 30, 2023 | -24.27 Mn |
| Mar 31, 2023 | -27.15 Mn |
| Dec 31, 2022 | -34.16 Mn |
| Sep 30, 2022 | -32.88 Mn |
| Jun 30, 2022 | -31.44 Mn |
| Mar 31, 2022 | -32.74 Mn |
| Dec 31, 2021 | -45.58 Mn |
| Sep 30, 2021 | -42.82 Mn |
| Jun 30, 2021 | -37.40 Mn |
| Mar 31, 2021 | -47.61 Mn |
| Dec 31, 2020 | -36.95 Mn |
| Sep 30, 2020 | -21.72 Mn |
| Jun 30, 2020 | -23.60 Mn |
| Mar 31, 2020 | -22.03 Mn |
| Dec 31, 2019 | -18.66 Mn |
| Sep 30, 2019 | -15.87 Mn |
| Jun 30, 2019 | -14.03 Mn |
| Mar 31, 2019 | -6.18 Mn |